C. Picard

Rapid Improvement after Starting Elexacaftor–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease

Pierre‐Régis Burgel, I. Durieu, R. Chiron et al. · American Journal of Respiratory and Critical Care Medicine · 2021 · 227 citations

Lung Abnormalities after Dasatinib Treatment for Chronic Myeloid Leukemia

Anne Bergeron, Delphine Réa, Vincent Lévy et al. · American Journal of Respiratory and Critical Care Medicine · 2007 · 182 citations

Fluid Retention, Imatinib Resistance, Translational Medicine +15

Prevalence and characteristics of <i>TERT</i> and <i>TERC</i> mutations in suspected genetic pulmonary fibrosis

Raphaël Borie, Laure Tabèze, Gabriel Thabut et al. · European Respiratory Journal · 2016 · 170 citations · Full text

Antibody-Mediated Rejection in Lung Transplantation: Clinical Outcomes and Donor-Specific Antibody Characteristics

Antoine Roux, Ines Bendib Le Lan, Sonia Holifanjaniaina et al. · American Journal of Transplantation · 2016 · 143 citations · Full text

Germline<i>SFTPA1</i>mutation in familial idiopathic interstitial pneumonia and lung cancer

Nadia Nathan, Violaine Giraud, C. Picard et al. · Human Molecular Genetics · 2016 · 142 citations · Full text

P.trp211arg Mutation, Engineering, Advanced Lung Disease +12